Clinical Trial Update: Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a dopamine agonist for non-functioning pituitary adenomas is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-functioning Pituitary Adenoma

Drugs mentioned

• Dopamine agonist (investigational)

Snippet

Sponsor: St. Olavs Hospital | Conditions: Pituitary Neoplasms, Adenoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING